Article

Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation

Topic: Business DevelopmentPublished June 24, 2021
No ratings yet297 viewsSign in to rate
The quality of active pharmaceutical ingredients (APIs) will directly affect the efficacy and safety of drugs. Alfa Chemistry has been an active player in the chemical industry and is committed to supplying what consumers exactly need. Guided by this, the company recently announces to have diversified its plentiful supply of varieties of active pharmaceutical ingredients, which could be used for pharmaceutical preparation. API refers to the biologically active component of a drug product, either in the form of tablet or capsule, thus API molecules have many chemical functional groups. All the drugs are made up of two central components, namely, APIs and pharmaceutical excipients. “The ever-growing demand for innovative medicines naturally leads to an increasing demand for efficient and effective management of APIs manufacturing. In such a case, our management has decided to diversify and upgrade our supply of APIs, trying to bring the best quality, high purified chemicals to our customers,” says the Marketing Chief of Alfa Chemistry. APIs may exist in the form of liquids, powders, crystals, and based on different sources, APIs can be categorized into synthetic chemical API, biotechnology API (traditional fermentation API and modern biotech API), natural API, with each type obtained by chemical synthesis, biotechnology, or plant extraction. As for now, Alfa Chemistry offers a variety of synthetic chemical APIs which can be used in the pharmaceutical preparation, which are listed as below:  Donepezilrn Dexmedetomidine Hydrochloride  Lenalidomidern Parecoxib Sodiumrn Rivaroxabanrn Tofacitinib Citratern Tamoxifen Citrate  Epalrestatrn Edaravone All APIs at Alfa Chemistry are strictly QC assessed so that high quality is guaranteed. Technique documents such as COA are also provided. In addition to APIs, Alfa Chemistry also offers pre-formulation drug discovery, formulation and process development, custom synthesis, and scale up services. Please visit the website: https://www.alfa-chemistry.com/ to learn more.

Further reading

Further Reading

4 total

Article

Artificial intelligence continues to dominate business conversations, but enthusiasm alone does not guarantee results. While many companies rush to adopt AI in hopes of gaining a competitive edge, a large number of initiatives still fall short. The problem is rarely the technology itself. More often, failure happens because organizations approach AI without the structure, readiness, and discipline required for long-term success. AI projects do not fail because the technology

March 4, 2026

Article

AI Avatar Development: Real Innovation or Just Hype? In today’s hyperconnected world, attention is currency. To stand out, brands can no longer settle for flashy features or surface-level engagement. They need to build meaningful, scalable, and personalized experiences. Enter AI avatars: digital humans that are revolutionizing communication by bringing lifelike presence to virtual interactions. Imagine a team member who never takes a coffee break, speaks ten languages fluen

February 27, 2026

Article

The Quiet Engine Behind Every Connection Most people think of telecom services as towers, signals, and mobile data moving invisibly through the air. Yet behind every call that connects and every message that reaches its destination, there is another system quietly working in the background. That system is the call center. While customers often interact with telecom companies only when something goes wrong, these centers operate constantly, guiding problems toward solutions an

February 23, 2026

Article

Introduction The solar industry once believed that collecting as many leads as possible was the fastest path to growth. Marketing teams focused on filling databases with names, phone numbers, and email addresses. At first, the numbers looked promising. Dashboards showed rising interest and more inquiries than ever before. Yet behind the scenes, many companies began to notice a quiet problem. Revenue growth did not match the flood of leads. Sales teams felt overwhelmed, conver

February 6, 2026